Document is current
Any future updates will be listed below
-
Authors
Guo, Gao
Gong, Ke
Beckley, Nicole
Zhang, Yue
Yang, Xiaoyao
Chkheidze, Rati
Hatanpaa, Kimmo J.
Garzon-Muvdi, Tomas
Koduru, Prasad
Nayab, Arifa
Jenks, Jennifer https://orcid.org/0000-0002-3150-3618
Sathe, Adwait Amod
Liu, Yan
Xing, Chao https://orcid.org/0000-0002-1838-0502
Wu, Shwu-Yuan
Chiang, Cheng-Ming
Mukherjee, Bipasha
Burma, Sandeep https://orcid.org/0000-0001-7057-9845
Wohlfeld, Bryan
Patel, Toral
Mickey, Bruce
Abdullah, Kalil
Youssef, Michael
Pan, Edward
Gerber, David E.
Tian, Shulan
Sarkaria, Jann N.
McBrayer, Samuel K.
Zhao, Dawen https://orcid.org/0000-0001-6428-1698
Habib, Amyn A. https://orcid.org/0000-0003-4164-9028
-
Funding
Funding for this research was provided by:
U.S. Department of Veterans Affairs (2I01BX002559-08)
Foundation for the National Institutes of Health (1R01CA244212-01A1)
Foundation for the National Institutes of Health (1R01NS119225-01A1)
Foundation for the National Institutes of Health (1RO1CA251698)
Foundation for the National Institutes of Health (R01CA258381)
Foundation for the National Institutes of Health (R01CA246807)
Foundation for the National Institutes of Health (R01 CA194578)
Cancer Prevention and Research Institute of Texas (RP190077)
Cancer Prevention and Research Institute of Texas (RR190034)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K24CA201543-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K22CA237752)
MIT/Mayo Physical Sciences Center for Drug Distribution and Efficacy in Brain Tumors
Cancer Prevention and Research Institute of Texas
- License Information
-
More Information
Article History
Received: 3 August 2021
Accepted: 14 June 2022
First Online: 1 August 2022
Competing interests
: The Department of Veteran’s Affairs has filed a patent (PCT/US2021/018716) on the use of tofacitinib in GBM, with A.A.H. as the inventor. The other authors declare no competing interests.
